Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
271.00    0.00 (0.00%)
Bid:
261.00
Ask:
271.00
Spread: 10.00 (3.831%)
Market Cap: £242.70m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

AGM Statement and Q1 Trading Update

1 Nov 2018 07:00

RNS Number : 9329F
Wilmington PLC
01 November 2018
 

1 November 2018 

 

Wilmington plc

('Wilmington', 'the Group' or 'the Company')

AGM Statement and Q1 Trading Update

 

Wilmington plc, the provider of information, education and networking services in Risk & Compliance, Healthcare and Professional knowledge areas, today announces a trading update for the three month period to 30 September 2018. This statement is being made ahead of its Annual General Meeting that is taking place later today.

 

Trading Update

 

In what is traditionally the quietest trading period for the Group, revenue performance in the first quarter has been reasonable, with a mix of performances across the different divisions. Overall revenue reduced 1% on an organic basis (i.e. at constant currencies and after adjusting for acquisitions and disposals) compared to the same period last year. This compares to the 3% organic revenue decline experienced across the prior year.

 

On a divisional basis, revenue in the Risk & Compliance division was up 7% organically, with good momentum in the main Compliance business, partly as a result of favourable timing issues that accelerated revenue from Q2 into the first three months this year. In the Healthcare division revenue declined 7% on an organic basis reflecting the reduction in deferred revenue noted in September's full year results announcement, as well as the continued impact of the decision to reduce US networking events to focus on improving profitability. Importantly from the perspective of future revenue progression in Healthcare, new business sales in the first quarter in the UK Healthcare business were up over 2% year on year and early indications for Q2 are that sales are expected to be further up compared to weak comparatives in the prior year. Revenue in the Professional businesses was flat year on year, excluding the impact of Ark, the legal services business that was closed in the first half of last year. 

 

Profit in the period, as anticipated, was down year on year due to the previously disclosed cost increases and investments made last year. This position was exacerbated slightly by a weaker than expected product mix in Q1 although this is expected to be a timing issue that will reverse over the course of the full year.

 

Net debt at 30 September 2018 was £44.4m (30 June 2018: £39.6m; 30 September 2017: £42.4m). The outflow since the start of the year is a function of usual seasonal outflows, and the final earn-out payment for SWAT which was acquired in July 2016.

 

Outlook

 

There is no change in anticipated trading outlook since the full year 2018 results announcement on 12 September 2018. The overall outcome from the divisional revenue and sales performance in the first quarter gives some early encouragement that momentum across the Group is starting to shift as required to achieve full year revenue and profit expectations. Whilst uncertainties remain within the macro economic environment, the changes in regulations that will come into force in the UK as a result of Brexit are likely to lead to new business opportunities in the second half of the year which will help to underpin our growth plans.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Richard Amos, Chief Financial Officer

 

FTI Consulting

Charles Palmer / Dwight Burden / Leah Dudley

020 7422 6800

 

 

 

020 3727 1000

 

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Healthcare and Professional areas. Wilmington employs close to 1,000 people and has customers in 120 countries. Wilmington plc is a premium listed company on the main market of the London Stock Exchange.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAKEFDLLPFFF
Date   Source Headline
12th Jan 200910:45 amRNSTotal Voting Rights
6th Jan 20093:10 pmRNSNotice of Results
9th Dec 20084:35 pmRNSPrice Monitoring Extension
4th Dec 20082:07 pmRNSTotal Voting Rights
27th Nov 20083:54 pmRNSAnnual Information Update
11th Nov 200810:00 amRNSBlocklisting Interim Review
11th Nov 20089:57 amRNSBlocklisting Interim Review
7th Nov 20081:44 pmRNSDirector/PDMR Shareholding
7th Nov 200810:00 amRNSDirector/PDMR Shareholding
6th Nov 20083:45 pmRNSVoting Rights and Capital
5th Nov 20084:38 pmRNSResult of AGM
5th Nov 20087:00 amRNSInterim Management Statement
29th Oct 20089:16 amRNSAnnual Report and Accounts
1st Oct 20084:04 pmRNSTotal Voting Rights
18th Sep 20087:44 amRNSPress Notice 114 Wilmington Group PLC
18th Sep 20087:00 amRNSFinal Results
15th Sep 20085:39 pmRNSTermination of offer talks
15th Sep 20082:39 pmRNSRule 8.3- Wilmington PLC
15th Sep 200810:55 amBUSEPT Disclosure
11th Sep 200810:52 amBUSEPT Disclosure
11th Sep 200810:51 amRNSEPT Disclosure
10th Sep 20082:15 pmRNSRule 8.3- Wilmington Group PL
10th Sep 200810:31 amBUSEPT Disclosure
8th Sep 20082:20 pmRNSRule 8.3- Wilmington Group PL
8th Sep 20081:25 pmRNSRule 8.3- Wilmington Grp
8th Sep 200810:53 amRNSEPT Disclosure
8th Sep 200810:40 amBUSEPT Disclosure
8th Sep 200810:00 amRNSNotice of Results
5th Sep 200810:40 amBUSEPT Disclosure
5th Sep 200810:19 amRNSEPT Disclosure
4th Sep 200810:50 amBUSEPT Disclosure
3rd Sep 200811:15 amRNSEPT Disclosure
3rd Sep 200810:50 amBUSEPT Disclosure
1st Sep 200811:05 amRNSEPT Disclosure
29th Aug 200811:18 amBUSEPT Disclosure
27th Aug 200810:03 amRNSEPT Disclosure
22nd Aug 200810:11 amBUSEPT Disclosure
22nd Aug 200810:02 amRNSEPT Disclosure
21st Aug 20083:38 pmRNSRule 8.3- Wilmington Group PL
21st Aug 200810:37 amRNSEPT Disclosure
21st Aug 200810:32 amBUSEPT Disclosure
20th Aug 200810:11 amBUSEPT Disclosure
19th Aug 200812:35 pmRNSRule 8.3- Wilmington Group PL
19th Aug 200812:16 pmRNSRule 8.3- (Wilmington Group P
19th Aug 200812:11 pmBUSRule 8.3 - WILMINGTON GROUP PLC ORD GBP 0.05
19th Aug 200811:20 amRNSEPT Disclosure
19th Aug 200810:13 amBUSEPT Disclosure
18th Aug 20089:45 amBUSEPT Disclosure
15th Aug 200810:19 amRNSEPT Disclosure
14th Aug 20082:41 pmRNSRule 8.3- WILMINGTON GROUP PL

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.